BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26082242)

  • 21. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of IL-4R enhances proliferation and invasion of hepatocellular carcinoma cells.
    Guo C; Ouyang Y; Cai J; Xiong L; Chen Y; Zeng X; Liu A
    Int J Biol Markers; 2017 Oct; 32(4):e384-e390. PubMed ID: 28665449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
    Wang JL; Yan TT; Long C; Cai WW
    Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.
    Yan X; Zhou H; Zhang T; Xu P; Zhang S; Huang W; Yang L; Gu X; Ni R; Zhang T
    Tumour Biol; 2015 Dec; 36(12):9611-9. PubMed ID: 26142732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.
    Wubetu GY; Utsunomiya T; Ishikawa D; Yamada S; Ikemoto T; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Kanamoto M; Zhu C; Bando Y; Shimada M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S721-8. PubMed ID: 24965572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HES5 promotes cell proliferation and invasion through activation of STAT3 and predicts poor survival in hepatocellular carcinoma.
    Zhu G; Shi W; Fan H; Zhang X; Xu J; Chen Y; Xu Z; Tao T; Cheng C
    Exp Mol Pathol; 2015 Dec; 99(3):474-84. PubMed ID: 26342546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
    Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
    BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
    He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L
    Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
    Tao QF; Yuan SX; Yang F; Yang S; Yang Y; Yuan JH; Wang ZG; Xu QG; Lin KY; Cai J; Yu J; Huang WL; Teng XL; Zhou CC; Wang F; Sun SH; Zhou WP
    Mol Cancer; 2015 Sep; 14():170. PubMed ID: 26376879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers.
    Ding Q; He D; He K; Zhang Q; Tang M; Dai J; Lv H; Wang X; Xiang G; Yu H
    Tumour Biol; 2015 Nov; 36(11):8761-72. PubMed ID: 26055142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
    Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
    J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
    Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB
    Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
    Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
    Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
    Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
    Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma.
    Li W; Liang Y; Yang B; Sun H; Wu W
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1085-93. PubMed ID: 25611915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
    Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
    J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
    Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
    Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.